A carregar...
Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance
BACKGROUND: Incretin-based therapies are rapidly becoming one of the main glycemic control strategies in diabetes. Considering the large numbers of papillary thyroid carcinomas (PTCs) and possible effects of glucagon-like peptide-1 (GLP-1) on cell proliferation, the expression of GLP-1 receptor (GLP...
Na minha lista:
| Publicado no: | Endocrinol Metab (Seoul) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Endocrine Society
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4285044/ https://ncbi.nlm.nih.gov/pubmed/25559577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2014.29.4.536 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|